Moomoo AI 已提取核心信息
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 3,760 shares of common stock on March 4, 2024. The transaction was executed in the open market at a price of $11.1212 per share, resulting in a total sale value of approximately $41,815.71. Following the sale, Matsuda Masaru's direct holdings in the company amount to 190,424 shares of common stock.
Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 3,760 shares of common stock on March 4, 2024. The transaction was executed in the open market at a price of $11.1212 per share, resulting in a total sale value of approximately $41,815.71. Following the sale, Matsuda Masaru's direct holdings in the company amount to 190,424 shares of common stock.
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的松田胜于2024年3月4日完成了3760股普通股的出售。该交易在公开市场上以每股11.1212美元的价格执行，总销售价值约为41,815.71美元。出售后，松田正直接持有的公司普通股为190,424股。
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的松田胜于2024年3月4日完成了3760股普通股的出售。该交易在公开市场上以每股11.1212美元的价格执行，总销售价值约为41,815.71美元。出售后，松田正直接持有的公司普通股为190,424股。
有用
没用